C. diff (Clostridioides difficile)
C. diff (Clostridioides difficile)
C. diff (Clostridioides difficile)
Results from the first long-term follow-up study of an oral vaccine for recurrent urinary tract infections (UTIs) suggest that it “could be a gamechanger for UTI prevention,” according to consultant urologist Bob Yang, who co-led the trial. “It’s very exciting… for us it was almost magical,” said Yang, who works with […]
Americans with Covid or other respiratory infections may return to daily activities if they don’t have a fever and their symptoms are improving. Americans with Covid or other respiratory infections need not isolate for five days before returning to work or school, the Centers for Disease Control and Prevention said […]
Summary What is already known about this topic? In the United States, the timing of seasonal respiratory syncytial virus (RSV) epidemics (October–April) was disrupted during the COVID-19 pandemic. What is added by this report? RSV circulation was historically low during 2020–21 and began earlier and continued longer during 2021–22 than […]
Summary What is already known about this topic? In the current global monkeypox outbreak, HIV infection and sexually transmitted infections (STIs) are highly prevalent among persons with monkeypox. What is added by this report? Among 1,969 persons with monkeypox in eight U.S. jurisdictions, 38% had HIV infection, and 41% had […]
A new omicron subvariant of the virus that causes COVID-19, BA.2, is quickly becoming the predominant source of infections amid rising cases around the world. Immunologists Prakash Nagarkatti and Mitzi Nagarkatti of the University of South Carolina explain what makes it different from previous variants, whether there will be another […]
Viral culture results and contact tracing data confirm that antigen tests may fail to catch 20% of symptomatic and >80% of asymptomatic COVID-19 cases. Lateral flow antigen tests (LFATs), also known as rapid antigen tests, use a device with an absorbent pad at one end and a reading window at […]
New omicron infections in the U.S. have plummeted 90% from a pandemic high in a little over a month. The U.S. is reporting about 84,000 new cases per day on average, according to data compiled by Johns Hopkins University, down from a pandemic high of more than 800,000 daily cases […]
The pivotal phase 3 clinical trials of the two-dose messenger RNA (mRNA) vaccines, among the largest ever conducted, led to the notable finding of ∼95% efficacy for prevention of symptomatic COVID-19 2 months after the second dose. Adenovirus vectored vaccines showed lower protection against infection with severe acute respiratory syndrome […]
As the omicron variant continues to spread throughout the world, new modeling data shows the latest strain may cause millions more new infections per day in the U.S. but fewer hospitalizations and deaths compared to the delta variant. Researchers at the Institute for Health Metrics and Evaluation at the University of Washington’s […]